Drug's impact on amino acid transporter may offer non-small cell lung cancer patients new hope
Tuesday, July 10, 2018 - 13:23
in Health & Medicine
An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that may predict the five-year survival rate of patients suffering from this cancer, now at 16 percent, researchers have concluded.